• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tn抗原与UDP - 半乳糖:N - 乙酰半乳糖胺α - Rβ1 - 3半乳糖基转移酶在人乳腺癌中的表达

Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.

作者信息

Zhuang D, Yousefi S, Dennis J W

机构信息

Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario.

出版信息

Cancer Biochem Biophys. 1991 Nov;12(3):185-98.

PMID:1844911
Abstract

The serine/threonine O-linked carbohydrates GalNAc alpha and Gal beta 1-3GalNAc alpha, referred to as Tn and T antigens, respectively, appear to be more prevalent in some human carcinomas than in surrounding tissues. Tn/T antigens may represent incomplete synthesis of O-linked oligosaccharides, due to decreased activity of specific glycosyltransferases, or alternatively, increased glycosidases activity in tumors which may expose these internal O-linked oligosaccharide sequences. To explore these possibilities, we measured UDP-Gal:GalNAc alpha-R beta 1-3 galactosyltransferase (beta 3Gal-T) and Gal beta 1-3GalNAc alpha-R beta 1-3 galactosidase in a series of human breast tumors. In addition, glycoproteins extracted from the tumors were separated by SDS-PAGE and stained with the lectins HPA (GalNAc alpha-R reactive) and PNA (Gal beta-3GalNAc alpha-R reactive). The relative levels of HPA- to PNA-reactive glycoproteins in the carcinomas correlated inversely with beta 3Gal-T activities. The results suggest that Tn antigen expression in human breast carcinoma is due in part to low beta 3Gal-T activity, a situation similar to that observed previously in haematopoietic cells of individuals with a condition called Tn syndrome.

摘要

丝氨酸/苏氨酸 O 连接碳水化合物 GalNAcα 和 Galβ1-3GalNAcα,分别称为 Tn 和 T 抗原,在某些人类癌组织中似乎比周围组织中更为普遍。Tn/T 抗原可能代表 O 连接寡糖的合成不完全,这是由于特定糖基转移酶活性降低,或者是由于肿瘤中糖苷酶活性增加,从而可能暴露这些内部 O 连接寡糖序列。为了探究这些可能性,我们在一系列人类乳腺肿瘤中测量了 UDP-半乳糖:GalNAcα-Rβ1-3 半乳糖基转移酶(β3Gal-T)和 Galβ1-3GalNAcα-Rβ1-3 半乳糖苷酶。此外,从肿瘤中提取的糖蛋白通过 SDS-PAGE 分离,并用凝集素 HPA(GalNAcα-R 反应性)和 PNA(Galβ-3GalNAcα-R 反应性)进行染色。癌组织中 HPA 反应性糖蛋白与 PNA 反应性糖蛋白的相对水平与 β3Gal-T 活性呈负相关。结果表明,人类乳腺癌中 Tn 抗原的表达部分归因于 β3Gal-T 活性低,这种情况与先前在患有 Tn 综合征个体的造血细胞中观察到的情况相似。

相似文献

1
Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.Tn抗原与UDP - 半乳糖:N - 乙酰半乳糖胺α - Rβ1 - 3半乳糖基转移酶在人乳腺癌中的表达
Cancer Biochem Biophys. 1991 Nov;12(3):185-98.
2
T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.来自一名患有永久性混合凝集活性患者的具有正常或缺陷性O-半乳糖基化的T细胞克隆。
Eur J Immunol. 1992 Jul;22(7):1835-42. doi: 10.1002/eji.1830220724.
3
Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.功能性等位基因的持续抑制可能是导致Tn综合征中半乳糖基转移酶缺乏的原因。
J Clin Invest. 1993 May;91(5):2103-10. doi: 10.1172/JCI116434.
4
Lectinochemical studies on the glyco-recognition factors of a Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Salvia sclarea.对从南欧丹参种子中分离出的一种Tn(GalNAcalpha1-->Ser/Thr)特异性凝集素的糖识别因子的凝集素化学研究。
J Biomed Sci. 2005;12(1):167-84. doi: 10.1007/s11373-004-8180-x.
5
Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.表达T抗原(β-半乳糖(1-3)N-乙酰半乳糖胺α1-O-R)和T样抗原的人膀胱癌糖缀合物:使用花生凝集素以及多克隆和单克隆抗体的比较研究
Cancer Res. 1992 Sep 15;52(18):5030-6.
6
Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line.来自正常人乳和BT-20人乳腺癌细胞系的DF3唾液粘蛋白抗原中的寡糖差异。
Cancer Commun. 1989;1(4):261-7.
7
[Expression of T and Tn antigens in breast cancers].[乳腺癌中T抗原和Tn抗原的表达]
C R Seances Soc Biol Fil. 1998;192(4):733-47.
8
Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.糖基转移酶在人结肠腺癌CaCo-2细胞分化过程中的变化。
Cancer Res. 1991 Jun 15;51(12):3136-42.
9
The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.癌细胞系中糖基转移酶和磺基转移酶活性模式:用于特征聚糖结构鉴定的个体癌症相关独特碳水化合物结构的预测指标。
Carbohydr Res. 2006 Jun 12;341(8):983-94. doi: 10.1016/j.carres.2006.02.017. Epub 2006 Mar 20.
10
Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.通过特异性单克隆抗体检测发现,神经节苷脂和唾液酸糖蛋白携带一种罕见血型抗原决定簇Cad,与人类癌症相关。
Cancer Res. 1990 Sep 1;50(17):5497-503.

引用本文的文献

1
Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer.癌症相关糖型和聚糖结合探针在体外诊断多变量指数分析中的应用,用于癌症的精确诊断。
Proteomics. 2016 Dec;16(24):3062-3072. doi: 10.1002/pmic.201500553. Epub 2016 May 11.
2
Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes.使用水性量子点分子探针体外评估乳腺癌切缘。
Int J Surg Oncol. 2012;2012:861257. doi: 10.1155/2012/861257. Epub 2012 Dec 24.
3
Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker.
花生凝集素结合型粘蛋白样糖蛋白在人食管鳞状细胞癌中的表达作为一种标志物
Mol Cancer. 2003 Nov 5;2:38. doi: 10.1186/1476-4598-2-38.
4
Glycosylations versus conformational preferences of cancer associated mucin core.癌症相关粘蛋白核心的糖基化与构象偏好
Glycoconj J. 2000 Dec;17(12):835-48. doi: 10.1023/a:1010909011496.
5
Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.结构明确的合成癌症疫苗:癌症相关粘蛋白MUC-1衍生肽的结构、糖基化及识别分析
Glycoconj J. 1995 Oct;12(5):607-17. doi: 10.1007/BF00731254.
6
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.使用合成唾液酸化-Tn糖缀合物加Detox佐剂对乳腺癌患者进行免疫接种。
Cancer Immunol Immunother. 1993;36(4):215-22. doi: 10.1007/BF01740902.